GPR180 is a component of TGFβ signalling that promotes thermogenic adipocyte function and mediates the metabolic effects of the adipocyte-secreted factor CTHRC1.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 12 2021
Historique:
received: 10 06 2021
accepted: 17 11 2021
entrez: 9 12 2021
pubmed: 10 12 2021
medline: 11 1 2022
Statut: epublish

Résumé

Activation of thermogenic brown and beige adipocytes is considered as a strategy to improve metabolic control. Here, we identify GPR180 as a receptor regulating brown and beige adipocyte function and whole-body glucose homeostasis, whose expression in humans is associated with improved metabolic control. We demonstrate that GPR180 is not a GPCR but a component of the TGFβ signalling pathway and regulates the activity of the TGFβ receptor complex through SMAD3 phosphorylation. In addition, using genetic and pharmacological tools, we provide evidence that GPR180 is required to manifest Collagen triple helix repeat containing 1 (CTHRC1) action to regulate brown and beige adipocyte activity and glucose homeostasis. In this work, we show that CTHRC1/GPR180 signalling integrates into the TGFβ signalling as an alternative axis to fine-tune and achieve low-grade activation of the pathway to prevent pathophysiological response while contributing to control of glucose and energy metabolism.

Identifiants

pubmed: 34880217
doi: 10.1038/s41467-021-27442-x
pii: 10.1038/s41467-021-27442-x
pmc: PMC8655035
doi:

Substances chimiques

CTHRC1 protein, human 0
Extracellular Matrix Proteins 0
GPR180 protein, human 0
Receptors, G-Protein-Coupled 0
Transforming Growth Factor beta 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7144

Informations de copyright

© 2021. The Author(s).

Références

Cannon, B. & Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277–359 (2004).
pubmed: 14715917 doi: 10.1152/physrev.00015.2003
Giralt, M. & Villarroya, F. White, brown, beige/brite: different adipose cells for different functions? Endocrinology 154, 2992–3000 (2013).
pubmed: 23782940 doi: 10.1210/en.2013-1403
Wu, J. et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366–376 (2012).
pubmed: 22796012 pmcid: 3402601 doi: 10.1016/j.cell.2012.05.016
Rosenwald, M., Perdikari, A., Rülicke, T. & Wolfrum, C. Bi-directional interconversion of brite and white adipocytes. Nat. Cell Biol. 15, 659–667 (2013).
pubmed: 23624403 doi: 10.1038/ncb2740
Ricquier, D., Casteilla, L. & Bouillaud, F. Molecular studies of the uncoupling protein. FASEB J. 5, 2237–2242 (1991).
pubmed: 1860614 doi: 10.1096/fasebj.5.9.1860614
Bartelt, A. et al. Brown adipose tissue activity controls triglyceride clearance. Nat. Med. 17, 200–205 (2011).
pubmed: 21258337 doi: 10.1038/nm.2297
Cypess, A. M. et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509–1517 (2009).
pubmed: 19357406 pmcid: 2859951 doi: 10.1056/NEJMoa0810780
Hany, T. F. et al. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur. J. Nucl. Med. Mol. Imaging 29, 1393–1398 (2002).
pubmed: 12271425 doi: 10.1007/s00259-002-0902-6
van Marken Lichtenbelt, W. D. et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500–1508 (2009).
pubmed: 19357405 doi: 10.1056/NEJMoa0808718
Chondronikola, M. et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes 63, 4089–4099 (2014).
pubmed: 25056438 pmcid: 4238005 doi: 10.2337/db14-0746
Iwen, K. A. et al. Cold-induced brown adipose tissue activity alters plasma fatty acids and improves glucose metabolism in men. J. Clin. Endocrinol. Metab. 102, 4226–4234 (2017).
pubmed: 28945846 doi: 10.1210/jc.2017-01250
Cypess, A. M. et al. Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. Cell Metab. 21, 33–38 (2015).
pubmed: 25565203 pmcid: 4298351 doi: 10.1016/j.cmet.2014.12.009
O’Mara, A. E. et al Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J. Clin. Invest. 130, 2209–2219 (2020).
pubmed: 31961826 pmcid: 7190915 doi: 10.1172/JCI131126
Forrester, E. et al. Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 65, 2296–2302 (2005).
pubmed: 15781643 doi: 10.1158/0008-5472.CAN-04-3272
Honjo, Y. et al. TGFβ receptor I conditional knockout mice develop spontaneous squamous cell carcinoma. Cell Cycle 6, 1360–1366 (2007).
pubmed: 17534148 doi: 10.4161/cc.6.11.4268
Babaei, R. et al. Jak-TGFβ cross-talk links transient adipose tissue inflammation to beige adipogenesis. Sci. Signal. 11, eaai7838 (2018).
pubmed: 29692363 doi: 10.1126/scisignal.aai7838
Higa, R. et al. CD105 maintains the thermogenic program of beige adipocytes by regulating Smad2 signaling. Mol. Cell. Endocrinol. 474, 184–193 (2018).
pubmed: 29574003 doi: 10.1016/j.mce.2018.03.008
Wankhade, U. D. et al. TGF-β receptor 1 regulates progenitors that promote browning of white fat. Mol. Metab. 16, 160–171 (2018).
pubmed: 30100246 pmcid: 6158128 doi: 10.1016/j.molmet.2018.07.008
Heldin, C.-H. & Moustakas, A. Signaling receptors for TGF-β family members. Cold Spring Harb. Perspect. Biol. 8, a022053 (2016).
pubmed: 27481709 pmcid: 4968163 doi: 10.1101/cshperspect.a022053
Li, Y., Fromme, T., Schweizer, S., Schöttl, T. & Klingenspor, M. Taking control over intracellular fatty acid levels is essential for the analysis of thermogenic function in cultured primary brown and brite/beige adipocytes. EMBO Rep. 15, 1069–1076 (2014).
pubmed: 25135951 pmcid: 4253847 doi: 10.15252/embr.201438775
Rahimi, N., Tremblay, E., McAdam, L., Roberts, A. & Elliott, B. Autocrine secretion of TGF-β1 and TGF-β2 by pre-adipocytes and adipocytes: a potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells. In Vitro Cell. Dev. Biol. Anim. 34, 412–420 (1998).
pubmed: 9639104 doi: 10.1007/s11626-998-0023-z
Chen, Y.-L., Wang, T.-H., Hsu, H.-C., Yuan, R.-H. & Jeng, Y.-M. Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. PLoS ONE 8, e70324 (2013).
pubmed: 23922981 pmcid: 3726622 doi: 10.1371/journal.pone.0070324
Guo, B. et al. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer. J. Ovarian Res. 10, 69 (2017).
pubmed: 29021002 pmcid: 5637322 doi: 10.1186/s13048-017-0358-8
Wang, C. et al. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. J. Exp. Clin. Cancer Res. 36, 84 (2017).
pubmed: 28645305 pmcid: 5481965 doi: 10.1186/s13046-017-0555-8
Yamamoto, S. et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev. Cell 15, 23–36 (2008).
pubmed: 18606138 doi: 10.1016/j.devcel.2008.05.007
Dratz, E. A. & Hargrave, P. A. The structure of rhodopsin and the rod outer segment disk membrane. Trends Biochem. Sci. 8, 128–131 (1983).
doi: 10.1016/0968-0004(83)90235-9
Palczewski, K. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739–745 (2000).
pubmed: 10926528 doi: 10.1126/science.289.5480.739
Tsukada, S. et al. Inhibition of experimental intimal thickening in mice lacking a novel G-protein–coupled receptor. Circulation 107, 313–319 (2003).
pubmed: 12538434 doi: 10.1161/01.CIR.0000043804.29963.B4
Yamauchi, T. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762–769 (2003).
pubmed: 12802337 doi: 10.1038/nature01705
Denard, B., Han, S., Kim, J., Ross, E. M. & Ye, J. Regulating G protein-coupled receptors by topological inversion. eLife 8, e40234 (2019).
pubmed: 30835201 pmcid: 6400500 doi: 10.7554/eLife.40234
Massagué, J. TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616–630 (2012).
pubmed: 22992590 pmcid: 4027049 doi: 10.1038/nrm3434
Christ, M. et al. Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. Baltim. Md 1950 153, 1936–1946 (1994).
Oshima, M., Oshima, H. & Taketo, M. M. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297–302 (1996).
pubmed: 8873772 doi: 10.1006/dbio.1996.0259
Zhu, Y., Richardson, J. A., Parada, L. F. & Graff, J. M. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703–714 (1998).
pubmed: 9753318 doi: 10.1016/S0092-8674(00)81730-4
Monteleone, G. et al. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108, 601–609 (2001).
pubmed: 11518734 pmcid: 209401 doi: 10.1172/JCI12821
Monteleone, G. et al. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn’s disease. N. Engl. J. Med. 372, 1104–1113 (2015).
pubmed: 25785968 doi: 10.1056/NEJMoa1407250
Yadav, H. et al. Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. Cell Metab. 14, 67–79 (2011).
pubmed: 21723505 pmcid: 3169298 doi: 10.1016/j.cmet.2011.04.013
Biernacka, A., Dobaczewski, M. & Frangogiannis, N. G. TGF-β signaling in fibrosis. Growth Factors 29, 196–202 (2011).
pubmed: 21740331 pmcid: 4408550 doi: 10.3109/08977194.2011.595714
Muraoka, R. S. et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109, 1551–1559 (2002).
pubmed: 12070302 pmcid: 151012 doi: 10.1172/JCI0215234
Mattson, M. P. Hormesis defined. Ageing Res. Rev. 7, 1–7 (2008).
pubmed: 18162444 doi: 10.1016/j.arr.2007.08.007
Wojciech, S. et al. The orphan GPR50 receptor promotes constitutive TGFβ receptor signaling and protects against cancer development. Nat. Commun. 9, 1216 (2018).
pubmed: 29572483 pmcid: 5865211 doi: 10.1038/s41467-018-03609-x
Bian, Z. et al. Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease. J. Autoimmun. 63, 76–87 (2015).
pubmed: 26238209 pmcid: 4644665 doi: 10.1016/j.jaut.2015.07.010
LeClair, R. J. et al. Cthrc1 is a novel inhibitor of transforming growth factor-β signaling and neointimal lesion formation. Circ. Res. 100, 826–833 (2007).
pubmed: 17322174 doi: 10.1161/01.RES.0000260806.99307.72
Li, J. et al. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling. EBioMedicine 40, 43–55 (2019).
pubmed: 30639416 pmcid: 6412555 doi: 10.1016/j.ebiom.2019.01.009
Pyagay, P. et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ. Res. 96, 261–268 (2005).
pubmed: 15618538 doi: 10.1161/01.RES.0000154262.07264.12
Balkow, A. et al. A novel crosstalk between Alk7 and cGMP signaling differentially regulates brown adipocyte function. Mol. Metab. 4, 576–583 (2015).
pubmed: 26266090 pmcid: 4529496 doi: 10.1016/j.molmet.2015.06.003
Hashimoto, O. et al. Activin E controls energy homeostasis in both brown and white adipose tissues as a hepatokine. Cell Rep. 25, 1193–1203 (2018).
pubmed: 30380411 doi: 10.1016/j.celrep.2018.10.008
Takahashi, H. et al. TGF-β2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism. Nat. Metab. 1, 291–303 (2019).
pubmed: 31032475 pmcid: 6481955 doi: 10.1038/s42255-018-0030-7
Klepac, K. et al. The Gq signalling pathway inhibits brown and beige adipose tissue. Nat. Commun. 7, 10895 (2016).
pubmed: 26955961 pmcid: 4786868 doi: 10.1038/ncomms10895
Balaz, M. et al. Inhibition of mevalonate pathway prevents adipocyte browning in mice and men by affecting protein prenylation. Cell Metab. 29, 901–916.e8 (2019).
pubmed: 30581121 doi: 10.1016/j.cmet.2018.11.017
Stohn, J. P. et al. Cthrc1 controls adipose tissue formation, body composition, and physical activity: Cthrc1 in Adipogenesis and Physical Activity. Obesity 23, 1633–1642 (2015).
pubmed: 26148471 doi: 10.1002/oby.21144
Stohn, J. P., Perreault, N. G., Wang, Q., Liaw, L. & Lindner, V. Cthrc1, a novel circulating hormone regulating metabolism. PLoS ONE 7, e47142 (2012).
pubmed: 23056600 pmcid: 3466254 doi: 10.1371/journal.pone.0047142
Fabbiano, S. et al. Caloric restriction leads to browning of white adipose tissue through type 2 immune signaling. Cell Metab. 24, 434–446 (2016).
pubmed: 27568549 doi: 10.1016/j.cmet.2016.07.023
Chiang, S.-H. et al. The protein kinase IKKɛ regulates energy balance in obese mice. Cell 138, 961–975 (2009).
pubmed: 19737522 pmcid: 2756060 doi: 10.1016/j.cell.2009.06.046
Duarte, C. W. et al. Elevated plasma levels of the pituitary hormone Cthrc1 in individuals with red hair but not in patients with solid tumors. PLoS ONE 9, e100449 (2014).
pubmed: 24945147 pmcid: 4063940 doi: 10.1371/journal.pone.0100449
Orava, J. et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 14, 272–279 (2011).
pubmed: 21803297 doi: 10.1016/j.cmet.2011.06.012
Balaz, M. et al. Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity: ZAG in Obesity and Metabolic Disease. Obesity 22, 1821–1829 (2014).
pubmed: 24753506 doi: 10.1002/oby.20764
Chen, S., Lee, B., Lee, A. Y.-F., Modzelewski, A. J. & He, L. Highly efficient mouse genome editing by CRISPR ribonucleoprotein electroporation of zygotes. J. Biol. Chem. 291, 14457–14467 (2016).
pubmed: 27151215 pmcid: 4938170 doi: 10.1074/jbc.M116.733154
Haueter, S. et al. Genetic vasectomy-overexpression of Prm1-EGFP fusion protein in elongating spermatids causes dominant male sterility in mice. Genes. N. Y. N. 2000 48, 151–160 (2010).
Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337–342 (2011).
pubmed: 21677750 pmcid: 3572410 doi: 10.1038/nature10163
Nathwani, A. C. et al. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107, 2653–2661 (2006).
pubmed: 16322469 pmcid: 1895379 doi: 10.1182/blood-2005-10-4035
Strobel, B. et al. Modeling pulmonary disease pathways using recombinant adeno-associated virus 6.2. Am. J. Respir. Cell Mol. Biol. 53, 291–302 (2015).
pubmed: 25845025 doi: 10.1165/rcmb.2014-0338MA
Enomoto, M., Bunge, M. B. & Tsoulfas, P. A multifunctional neurotrophin with reduced affinity to p75NTR enhances transplanted Schwann cell survival and axon growth after spinal cord injury. Exp. Neurol. 248, 170–182 (2013).
pubmed: 23792206 doi: 10.1016/j.expneurol.2013.06.013
Zawel, L. et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611–617 (1998).
pubmed: 9660945 doi: 10.1016/S1097-2765(00)80061-1
Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–527 (2016).
pubmed: 27043002 doi: 10.1038/nbt.3519
Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766–D773 (2019).
pubmed: 30357393 doi: 10.1093/nar/gky955
Andrews, S. FastQC: a quality control tool for high throughput sequence data. (Babraham Bioinformatics, Babraham Institute, 2010).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
pubmed: 30395289 doi: 10.1093/nar/gky1106

Auteurs

Lucia Balazova (L)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Miroslav Balaz (M)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Institute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of Sciences, 84505, Bratislava, Slovakia.
Department of Animal Physiology and Ethology, Faculty of Natural Sciences, Comenius University in Bratislava, 84215, Bratislava, Slovakia.

Carla Horvath (C)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Áron Horváth (Á)

Biomechanics Laboratory, University Hospital Balgrist, University of Zurich, 8008, Zurich, Switzerland.
Institute of Biomechanics, ETH Zurich, 8093, Zurich, Switzerland.

Caroline Moser (C)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Zuzana Kovanicova (Z)

Institute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of Sciences, 84505, Bratislava, Slovakia.

Adhideb Ghosh (A)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Functional Genomics Centre Zurich, ETH Zurich/ University of Zurich, 8057, Zurich, Switzerland.

Umesh Ghoshdastider (U)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Vissarion Efthymiou (V)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Elke Kiehlmann (E)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Wenfei Sun (W)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Hua Dong (H)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Lianggong Ding (L)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.

Ez-Zoubir Amri (EZ)

Université Côte d'Azur, French National Centre for Scientific Research, Inserm, iBV, 06107, Nice, France.

Pirjo Nuutila (P)

Turku PET Centre, University of Turku, 20520, Turku, Finland.

Kirsi A Virtanen (KA)

Turku PET Centre, University of Turku, 20520, Turku, Finland.

Tarja Niemi (T)

Department of Surgery, Turku University Hospital, 20520, Turku, Finland.

Barbara Ukropcova (B)

Institute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of Sciences, 84505, Bratislava, Slovakia.
Institute of Pathophysiology, Faculty of Medicine, Comenius University, 81108, Bratislava, Slovakia.

Jozef Ukropec (J)

Institute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of Sciences, 84505, Bratislava, Slovakia.

Pawel Pelczar (P)

Center for Transgenic Models, University of Basel, 3350, Basel, Switzerland.

Thorsten Lamla (T)

Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach an der Riss, Germany.

Bradford Hamilton (B)

Cardiometabolic Diseases Research Department, Boehringer Ingelheim Pharma GmbH and Co. KG, 88397, Biberach an der Riss, Germany.

Heike Neubauer (H)

Cardiometabolic Diseases Research Department, Boehringer Ingelheim Pharma GmbH and Co. KG, 88397, Biberach an der Riss, Germany.

Christian Wolfrum (C)

Institute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland. christian-wolfrum@ethz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH